Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control studyJamie Lopez Bernal, Mary Ramsay, Nick Andrews et al.|BMJ|2021Cited by 1.4k
Estimated number of deaths directly averted in people 60 years and older as a result of COVID-19 vaccination in the WHO European Region, December 2020 to November 2021Margaux M. I. Meslé, Richard Pebody, Jeremy Brown et al.|Eurosurveillance|2021Cited by 281
Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in EnglandJamie Lopez Bernal, Mary Ramsay, Nick Andrews et al.|medRxiv|2021Cited by 204
European all-cause excess and influenza-attributable mortality in the 2017/18 season: should the burden of influenza B be reconsidered?Jens Nielsen, Tyra Grove Krause, Mikko Virtanen et al.|Clinical Microbiology and Infection|2019Cited by 140
Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studiesMarc Rondy, Esther Kissling, Hanne‐Dorthe Emborg et al.|Eurosurveillance|2018Cited by 123